loadpatents
name:-0.020632028579712
name:-0.0011730194091797
name:-0.0026090145111084
Slawin; Kevin M. Patent Filings

Slawin; Kevin M.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Slawin; Kevin M..The latest application filed is for "methods for controlled activation or elimination of therapeutic cells".

Company Profile
1.0.13
  • Slawin; Kevin M. - Houston TX
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Methods For Controlled Activation Or Elimination Of Therapeutic Cells
App 20220152100 - Spencer; David Michael ;   et al.
2022-05-19
Methods For Controlled Elimination Of Therapeutic Cells
App 20220125837 - Spencer; David M. ;   et al.
2022-04-28
Methods For Controlled Activation Or Elimination Of Therapeutic Cells
App 20160175359 - SPENCER; David M. ;   et al.
2016-06-23
Methods For Controlled Elimination Of Therapeutic Cells
App 20160166613 - SPENCER; David M. ;   et al.
2016-06-16
Inhibition Of The Sh2-domain Containing Protein Tyr-phosphatase, Shp-1, To Enhance Vaccines
App 20090123501 - Levitt; Jonathan ;   et al.
2009-05-14
Method To Predict Risk Of Bph Progression
App 20070134725 - Slawin; Kevin M. ;   et al.
2007-06-14
Genetic markers associated with benign prostatic hyperplasia
App 20060194230 - Levitt; Jonathan ;   et al.
2006-08-31
Method to predict prostate cancer
App 20050282199 - Slawin, Kevin M. ;   et al.
2005-12-22
Regulated apoptosis using chemically induced dimerization of apoptosis factors
App 20040040047 - Spencer, David M. ;   et al.
2004-02-26
Method to determine outcome for patients with prostatic disease
App 20030235816 - Slawin, Kevin M. ;   et al.
2003-12-25
Method for detection of micrometastatic prostate cancer
App 20030113743 - Slawin, Kevin M. ;   et al.
2003-06-19
Method to determine prognosis after therapy for prostate cancer
App 20030054419 - Slawin, Kevin M. ;   et al.
2003-03-20
Methods to determine prognosis after therapy for bladder cancer
App 20030032074 - Slawin, Kevin M. ;   et al.
2003-02-13
Company Registrations
SEC0001626808Slawin Kevin M.

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed